Research Report Screener Results

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 10-Feb-2010
New Screen

All Reports | Brokerage Reports | Independent Reports

All Reports (Showing 1 to 10 of 21)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
9-Feb-10 New Constructs, LLC N/A TBV: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings 19 $10 View Abstract
8-Feb-10 ValuEngine, Inc. N/A ValuEngine Detailed Valuation Report for TBV 13 $25 View Abstract
6-Feb-10 Reuters Investment Profile N/A Tiens Biotech Group (USA) Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 12 $20 View Abstract
5-Feb-10 Validea N/A Validea Guru Analysis Report for TBV. Analysis using Validea's interpretation of the published quantitative strategies of well-known Wall Street experts including Peter Lynch, Warren Buffett, Ben Graham and Ken Fisher, among others. N/A $18 View Abstract
5-Feb-10 Ford Investor Services, Inc. N/A Value Graph: TIENS BIOTECH GP -- TBV 1 $4 View Abstract
5-Feb-10 Ford Investor Services, Inc. N/A Industry Value Graph: INBP , MDNU , NAII , NUTR , NXXI , RELV , TBV -- PACKAGED FOOD 3 $4 View Abstract
5-Feb-10 Jefferson Research N/A Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of TIENS BIOTECH GROUP USA INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. 11 $20 View Abstract
4-Feb-10 New Constructs, LLC N/A Most Attractive Stocks on the Market -- February's 20 Large Cap and 20 Small Cap Undervalued Opportunities 11 $50 View Abstract
4-Feb-10 New Constructs, LLC N/A Most Dangerous Stocks on the Market -- February's 20 Large Cap and 20 Small Cap Undervalued Opportunities 11 $50 View Abstract
2-Feb-10 Wright Reports N/A Wright Investors Service Comprehensive Report for Tiens Biotech Group (USA), Inc. 40 $65 View Abstract
Next 11

Independent Reports (Showing 1 to 10 of 21)

Release
Date Contributor Author Title Pages Price More Info
9-Feb-10 New Constructs, LLC N/A TBV: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings 19 $10 View Abstract
8-Feb-10 ValuEngine, Inc. N/A ValuEngine Detailed Valuation Report for TBV 13 $25 View Abstract
6-Feb-10 Reuters Investment Profile N/A Tiens Biotech Group (USA) Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 12 $20 View Abstract
5-Feb-10 Validea N/A Validea Guru Analysis Report for TBV. Analysis using Validea's interpretation of the published quantitative strategies of well-known Wall Street experts including Peter Lynch, Warren Buffett, Ben Graham and Ken Fisher, among others. N/A $18 View Abstract
5-Feb-10 Ford Investor Services, Inc. N/A Value Graph: TIENS BIOTECH GP -- TBV 1 $4 View Abstract
5-Feb-10 Ford Investor Services, Inc. N/A Industry Value Graph: INBP , MDNU , NAII , NUTR , NXXI , RELV , TBV -- PACKAGED FOOD 3 $4 View Abstract
5-Feb-10 Jefferson Research N/A Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of TIENS BIOTECH GROUP USA INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. 11 $20 View Abstract
4-Feb-10 New Constructs, LLC N/A Most Attractive Stocks on the Market -- February's 20 Large Cap and 20 Small Cap Undervalued Opportunities 11 $50 View Abstract
4-Feb-10 New Constructs, LLC N/A Most Dangerous Stocks on the Market -- February's 20 Large Cap and 20 Small Cap Undervalued Opportunities 11 $50 View Abstract
2-Feb-10 Wright Reports N/A Wright Investors Service Comprehensive Report for Tiens Biotech Group (USA), Inc. 40 $65 View Abstract
Next 11

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.